He holds a Degree in Medicine and Surgery from the University of Bologna, a PhD in Clinical Genetics from Sapienza University of Rome, and a Master’s in Research Governance from the University of Modena and Reggio Emilia, and was a Visiting Scientist at the US National Cancer Institute. He is Director of the Department of Rare Skeletal Diseases and five National Rare Disease Registries at the Rizzoli Orthopedic Institute, and coordinates ERN BOND, a network of 50 Centers of Excellence across 20 EU countries. He also serves as Delegate to the Italian Ministry of Health for ERN integration. He directs BIOGEN and coordinates major biobank networks, and previously held leadership roles in BBMRI-ERIC and the European Medicines Agency. He leads European research projects on rare diseases and clinical trials. He has authored over 120 scientific publications, served as President of leading international scientific societies, and is a member of several patient organization scientific committees.
